AzTrials
AzTrials

Nerve BlockBlock-aidNCT07849049

Training Non-Anesthesia Personnel to Perform Nerve Blocks in Microgravity

A study testing Simulated microgravity and Normal earth gravity in people with Nerve Block and Regional Anesthesia, run by Nova Scotia Health Authority at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Space exploration is rapidly progressing with multiple upcoming missions planned to the moon and International Space Station, and projected missions to Mars in the early 2030s. Multiple types of injuries and surgical emergencies are possible during space travel. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Nerve Block, Regional Anesthesia, Microgravity
What is being tested?
Simulated microgravity and Normal earth gravity
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteCanada
Study dates
20 Mar 2026to 29 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult (age >18 years)
  • certified scuba divers
  • no prior nerve block technique training.
  • staff anesthesiologists or senior residents
  • certified scuba divers

Who cannot join

  • active ear nose and throat conditions that prevent ear equalization
  • neuromotor conditions interfering with fine motor skills
  • pregnancy
  • inability to consent

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Survival Systems Training Limited

    Dartmouth, Nova Scotia, B2Y 4K9

Other trials in Canada

About this study

Official title: Training Non-Anesthesia Personnel to Perform Nerve Blocks in Microgravity: A Prospective Cohort Study

Space exploration is rapidly progressing with multiple upcoming missions planned to the moon and International Space Station, and projected missions to Mars in the early 2030s. Multiple types of injuries and surgical emergencies are possible during space travel. With the rapidly increasing number of travelers, healthcare providers need to refine our plans for responding to surgical emergencies in space.

It may not be possible to return injured crew members to earth for medical treatment depending on distance from earth and the severity of the injury. Furthermore, the casualty's physiologic changes in microgravity, and logistical limitations of repatriation make addressing medical emergencies challenging. Pain medications and general anesthesia have side effects that can impact safety in space and have worse side effect profiles when compared to on earth.

Read more

Regional anesthesia, injecting local anesthetic near to a nerve(s) to create a large area of numbness on the body, has been used for many years for pain management and to allow for surgery in remote settings on earth. Military personnel have used these techniques to provide effective pain control for evacuating wounded soldiers, while maintaining their cognition. For these reasons, regional anesthesia (aka 'nerve block') has been promoted as a viable solution for injured astronauts.

Our team has demonstrated that simple nerve blocks are possible in simulated microgravity among trained anesthesia providers. Recognizing that non-physician medical technicians may be integral to future space missions, this study aims to ascertain the feasibility of training such personnel to perform simple nerve blocks in microgravity.

Read the detailed description

With the burgeoning human presence in space, the need to prepare for medical emergencies in microgravity environments becomes increasingly critical. Space is an inherently hazardous environment, with 21 known fatalities. Most injuries occur during lift off or re-entry, but in-flight incidents have also been reported, including fires, blunt injuries, vehicular collisions, and loss of environmental controls. Extraction times vary significantly, with the potential for hours in low-earth orbit (LEO), days from the Moon, and months from Mars. In this case or during more distant space exploration, damage control procedures may be necessary.

If astronauts are injured, physiologic and logistic complexities necessitate a different approach from hospital-based care on Earth. In addition, due to ergonomic challenges of microgravity. Systemic pain medication is not optimal in that it can cause sedation, confusion, and even delirium. This could compromise safety for the crew given the small numbers of personnel who play critical roles. If a surgical intervention was required, general anesthesia is problematic for multiple reasons.

The benefits of regional anesthesia (nerve blocks) have been recognized in remote settings, including regions with fewer resources and trained providers. Regional anesthesia limits airway management, ventilation, and hemodynamic changes. The equipment is portable, offers stable hemodynamics, effective analgesia, minimal need for supplemental oxygen, and improved alertness. As each crew member's role is pivotal for mission success, regional anesthesia ensures their cognitive participation. Our group has shown that nerve blocks are feasible in a simulated microgravity environment when performed by anesthesiologists and anesthesia residents.

In specialized teams such as astronauts, rigorously trained for space exploration, there might not be the depth of personnel to allow physicians on crews. At the current time, most missions have a single Crew Medical Officer (CMO) who is usually not a physician. Space travel with its associated communication and logistical delays further emphasizes the need for such medical training so they can act without real-time guidance.

Aim Recognizing that non-physician medical technicians may be integral to future space missions, our study aims to ascertain the feasibility of training such personnel to perform simple nerve blocks in microgravity.

Hypothesis The investigators hypothesize that despite training about nerve block mechanics and ultrasound imaging, non-physician personnel have worse accuracy, time to injection, and ease of needle placement in a simulated microgravity environment than compared to normal gravity conditions. Furthermore, the investigators hypothesize that accuracy, time to injection, and ease of needle placement will be inferior to anesthesia providers in a simulated microgravity environment.

Methods This will be a prospective cohort study using within- and between-subjects comparisons. This study will assess the ease and success of ultrasound-guided injections ("nerve blocks") by non-anesthesia personnel comparing normal gravity to microgravity conditions using a meat model. Secondly, the ease and success rate of non-anesthesia participants will be compared to anesthesia participants.

Recruitment and Allocation The investigators will recruit 20 non-anesthesia military personnel and 5 anesthesia providers who are trained scuba divers. Inclusion criteria for the non-anesthesia group would be adult (age >18 years) certified scuba divers and those who have not had prior nerve block technique training. Inclusion criteria for the anesthesia group are that they are staff anesthesiologists or senior residents and certified scuba divers since nerve block training is part of basic anesthesia training.

Training session Recruited participants would be given a 4-hour training session on ultrasound imaging theory and practical optimization, needle visualization and control, basics of local anesthetics, basic sono-anatomy, and complications of nerve blocks. This session will be developed and led by regional anesthesia fellowship trained team members. There will be opportunities to practice image acquisition and needle placement with feedback. This session will take place the day before the study.

Meat model creation All injections will use a meat model. This meat model using beef muscle, beef tendon, and ballistics gel has been previously validated for accessing accuracy of US-guided injections.

Gravity conditions In the normal gravity condition, participants will be in a seated position with the meat model positioned in the chest wall of a mannikin, supported on a table. The ultrasound, phone, and dive case will be the same as in the microgravity condition. Participants will use hand signals to communicate with their block assistant since verbal communication will not be possible underwater.

In the microgravity condition, the participants will be scuba diving in a pool. The mannikin will be secured to a table at the bottom of the pool and they will empty their buoyancy control device (causing them to sink), effectively removing the added complexity of buoyancy control. An investigator will assist each participant with the block by positioning the meat model in the mannikin, passing equipment, and injecting the dye through a syringe once they are signalled to do so. However, the investigator will not give the participant guidance on the accuracy of the needle position or the quality of their ultrasound image.

Statistical analysis and power calculation Demographics will be collected (age, gender, prior medical training, experience with nerve blocks) and reported in aggregate for the purposes of external validity and generalizability. Outcomes will be compared between normal gravity and microgravity for non-anesthesia participants (within subjects, paired data). Outcomes will also be compared between anesthesia and non-anesthesia participants (between subjects, independent data).

Data will be analyzed using generalized estimating equations to adjust for the clustered nature of the data (i.e., blocks nested within participants). For binary outcomes (success vs. failure), a binomial outcome with a logit link will be used. For numerical outcomes, a normal distribution will be assumed, though loglinear models for skewed distributions will also be explored if they fit the data better.

Power analyses adjust sample sizes for the clustered design using the design effect method described by Bland (2004). Moreover, the design assumes 14 blocks per participant. The first a-priori power analysis is for comparing normal gravity and microgravity for non-anesthesia participants with the outcome of success vs. failure. Assuming a one-tailed alpha of 0.05, power of 80%, a normal gravity success rate of 90% and a microgravity success rate of 70%, and an intraclass correlation of 0.10, a total of 19 non-anesthesia participants will be required.

The second a-priori power analysis is for comparing normal gravity and microgravity for non-anesthesia participants for time to block, which has been used as a measure of ease in learning curve studies. Assuming a one-tailed alpha of 0.05, power of 80%, a mean difference of 12 seconds, a standard deviation of 23 seconds (based on data from our prior study), and an intraclass correlation of 0.10, a total of 15 participants will be needed.

Being tested
Simulated microgravity, Normal earth gravity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Simulated microgravityOther

    Neutral buoyancy underwater

  • Normal earth gravityOther

    Same procedure on land

Study groups in NCT07849049
Study groupRoleWhat they receive
Simulated MicrogravityExperimentalIn the microgravity condition, the participants will be scuba diving in a pool. The mannikin will be secured to a table at the bottom of the pool and they will empty their buoyancy control device (causing them to sink), effectively removing the added complexity of buoyancy control. An investigator will assist each participant with the block by positioning the meat model in the mannikin, passing equipment, and injecting the dye through a syringe once they are signaled to do so. However, the investigator will not give the participant guidance on the accuracy of the needle position or the quality of their ultrasound image.
Receives: Other: Simulated microgravity
Normal gravityActive comparatorIn the normal gravity condition, participants will be in a seated position with the meat model positioned in the chest wall of a mannikin, supported on a table. Participants will use a high-frequency (4-13 MHz) linear transducer and a 22G 50 mm echogenic needle to inject the meat model with 1-2 ml of water mixed with blue food coloring. The ultrasound, phone, and dive case will be the same as in the microgravity condition. Participants will use hand signals to communicate with their block assistant since verbal communication will not be possible underwater.
Receives: Other: Normal earth gravity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Injection success

    Post-injection the models will be stored in a refrigerator for at least 24 hours to dry and allow the dye to settle. Two blinded investigators will dissect the models and score them. A successful nerve block will be defined as visible blue dye staining the outside of the beef tendon without evidence of injection inside of the tendon. The presence of primarily intraneural or intramuscular staining will be considered a failed block.

    Measured: 3.5 minutes

Secondary outcomes (5)
  1. Time to injection

    Defined as the time from the transducer first touching the nerve block model to when the needle was removed from the model.

    Time was censored at 3.5 minutes, such as the participants were signalled to stop at the maximum time and the attempt was recorded as incomplete (due to time constraints).

    Measured: 3.5 minutes

  2. Number of needle passes

    Any needle passes that appeared to contact the tendon (simulated nerve), judged by noticeable movement of the tendon, were be recorded by the investigator. The number of needle passes were also recorded, judged as the number of times the needle was withdrawn and repositioned (adjustments in trajectory were not counted).

    Measured: 3.5 minutes

  3. Ease of ultrasound image acquisition

    Scored immediately after each block in both conditions using a 5-point Likert scale (1 = very difficult, 2 = difficult, 3 = neutral, 4 = easy, 5 = very easy).

    Measured: 5 minutes

  4. Ease of needle placement

    Scored immediately after each block in both conditions using a 5-point Likert scale (1 = very difficult, 2 = difficult, 3 = neutral, 4 = easy, 5 = very easy).

    Measured: 5 minutes

  5. Intraneural injection

    Post-injection the models were be stored in a refrigerator for at least 24 hours to dry and allow the dye to settle. Two blinded investigators dissected the models to score the position of the dye. The presence of dye within the tendon will be considered an "intraneural" injection.

    Measured: 3.5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2026
  2. Study start20 Mar 2026
  3. Primary completion29 Mar 2026
  4. Study completion29 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
This will be a prospective cohort study using within- and between-subjects comparisons. This study will assess the ease and success of ultrasound-guided injections ("nerve blocks") by non-anesthesia personnel comparing normal gravity to microgravity conditions using a meat model. Secondly, the ease and success rate of non-anesthesia participants will be compared to anesthesia participants.
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07849049
Sponsor's protocol ID
REB # 2024-7417
Acronym
Block-aid
Status last verified
Sep 2026
First submitted
17 Sep 2026
Last updated
30 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Ability to share would be based on ethical and Canadian Armed Forces approval on a case by case basis.

Publications

  • Kiberd MB, Brownbridge R, Mackin M, Werry D, Bird S, Barry G, Bailey JG. Feasibility of ultrasound-guided nerve blocks in simulated microgravity: a proof-of-concept study for regional anaesthesia during deep space missions. Br J Anaesth. 2024 Dec;133(6):1276-1283. doi: 10.1016/j.bja.2024.07.034. Epub 2024 Sep 25.

    PubMed 39327151
  • Brownbridge RG, Kiberd MB, Werry D, Bailey JG. Discriminative Ability of Dye Injected Into a Meat Model to Determine Accuracy of Ultrasound-Guided Injection. Simul Healthc. 2025 Feb 1;20(1):54-60. doi: 10.1097/SIH.0000000000000799. Epub 2024 Jun 10.

    PubMed 38856652
  • Komorowski M, Thierry S, Stark C, Sykes M, Hinkelbein J. On the Challenges of Anesthesia and Surgery during Interplanetary Spaceflight. Anesthesiology. 2021 Jul 1;135(1):155-163. doi: 10.1097/ALN.0000000000003789. No abstract available.

    PubMed 33940633
  • Scarpa J, Wu CL. The role for regional anesthesia in medical emergencies during deep space flight. Reg Anesth Pain Med. 2021 Oct;46(10):919-922. doi: 10.1136/rapm-2021-102710. Epub 2021 May 21.

    PubMed 34021077
  • Anderton R, Posselt B, Komorowski M, Hodkinson P. Medical considerations for a return to the Moon. Occup Med (Lond). 2019 Aug 22;69(5):311-313. doi: 10.1093/occmed/kqz099. No abstract available.

    PubMed 31436819
  • Komorowski M, Fleming S, Mawkin M, Hinkelbein J. Anaesthesia in austere environments: literature review and considerations for future space exploration missions. NPJ Microgravity. 2018 Feb 23;4:5. doi: 10.1038/s41526-018-0039-y. eCollection 2018.

    PubMed 29507873

Questions about this trial

What is this clinical trial studying?

A study testing Simulated microgravity and Normal earth gravity in people with Nerve Block and Regional Anesthesia, run by Nova Scotia Health Authority at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Injection success (time frame: 3.5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07849049, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in